Quick Takeaways
- Era Regenerative Medicine Ltd filed SCHEDULE 13D/A for REED'S, INC. Common Stock (REED).
- Disclosed ownership: 60%.
- Date of event: 16 Apr 2025.
Era Regenerative Medicine Ltd - 16 Apr 2025 SCHEDULE 13D/A Report for REED'S, INC. Common Stock (REED)
- Filing Manager
- Era Regenerative Medicine Ltd
- Reporting Manager
- Era Regenerative Medicine Ltd
- Security
- REED'S, INC. Common Stock
- Symbol
- REED
- Shares outstanding
- 45,612,639 shares
- Disclosed Ownership
- 27,139,520 shares
- Ownership
- 60%
- Form type
- SCHEDULE 13D/A
- Filing time
- 02 May 2025, 17:35:16 UTC
- Date of event
- 16 Apr 2025
- Previous filing
- 28 Feb 2025
- Next filing
- 11 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Era Regenerative Medicine Ltd disclosed 60% ownership in REED'S, INC. Common Stock (REED) on 16 Apr 2025."
What Changed
- Previous schedule filing date: 28 Feb 2025.
- Current filing was accepted on 02 May 2025, 17:35.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Era Regenerative Medicine Ltd | 60% | 27,139,520 | 0 | 27,139,520 | /s/ Dai Siqi | Dai Siqi, Director | 0002053961 |
| D&D Source of Life Holding Ltd. | 60% | 27,139,520 | 0 | 27,139,520 | /s/ Dai Siqi | Dai Siqi, on behalf of Era Regenerative Medicine Ltd as its Director | 0001979652 |